We are live on ! Find out more
D.E. Shaw & Co

D.E. Shaw & Co Portfolio holdings

AUM $166B
1-Year Est. Return 43.98%
 

D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.

This Fund
S&P 500
This Quarter Est. Return
+8.35%
1 Year Est. Return
+43.98%
3 Year Est. Return
+138.44%
5 Year Est. Return
+164.23%
10 Year Est. Return
+713.02%
AUM
$116B
AUM Growth
+$12.3B
Cap. Flow
-$2.57B
Cap. Flow %
-2.21%
Top 10 Hldgs %
9.91%
Holding
5,208
New
1,193
Increased
1,491
Reduced
1,580
Closed
489

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$672M
2
MRK icon
Merck
MRK
+$476M
3
META icon
Meta Platforms (Facebook)
META
+$392M
4
MCD icon
McDonald's
MCD
+$372M
5
WFC icon
Wells Fargo
WFC
+$357M

Sector Composition

Rank Sector Weight
1 Technology 15.62%
2 Consumer Discretionary 9.84%
3 Healthcare 7.45%
4 Communication Services 7.19%
5 Financials 5.87%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IDN icon
4376
Intellicheck
IDN
$73.5M
$110K ﹤0.01%
+13,190
New +$108K
MNOV icon
4377
MediciNova
MNOV
$65M
$106K ﹤0.01%
24,871
-7,831
-24% -$33.7K
LOTZ
4378
DELISTED
CarLotz, Inc. Class A Common Stock
LOTZ
$106K ﹤0.01%
+19,351
New +$122K
TMAC.WS
4379
DELISTED
The Music Acquisition Corporation Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50
TMAC.WS
$106K ﹤0.01%
+125,000
New +$85K
STSA
4380
DELISTED
Satsuma Pharmaceuticals, Inc. Common Stock
STSA
$103K ﹤0.01%
+14,628
New +$78.9K
NAACU
4381
DELISTED
North Atlantic Acquisition Corporation Unit
NAACU
$102K ﹤0.01%
+10,104
New +$101K
BWACW
4382
DELISTED
BETTER WORLD ACQUISITION CORP. Warrants
BWACW
$101K ﹤0.01%
100,770
VXRT
4383
DELISTED
Vaxart
VXRT
$100K ﹤0.01%
+13,416
New +$93.7K
CLAS.WS
4384
DELISTED
Class Acceleration Corp. Redeemable Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50
CLAS.WS
$99K ﹤0.01%
125,000
NIRWW
4385
DELISTED
Near Intelligence, Inc. Warrant
NIRWW
$98K ﹤0.01%
125,000
KAHC.WS
4386
DELISTED
KKR Acquisition Holdings I Corp. Redeemable Warrants, each whole Warrant exercisable for one share of Class A Common Stock, each at an exercise price of $11.50 per share
KAHC.WS
$98K ﹤0.01%
+83,333
New +$96.1K
VKTX icon
4387
Viking Therapeutics
VKTX
$4.04B
$97K ﹤0.01%
16,273
-2,966
-15% -$17.6K
MBAC.WS
4388
DELISTED
M3-Brigade Acquisition II Corp. Redeemable Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50
MBAC.WS
$96K ﹤0.01%
+83,333
New +$69.8K
GNPX icon
4389
Genprex
GNPX
$3.94M
$95K ﹤0.01%
+1
New +$164K
UAVS icon
4390
AgEagle Aerial Systems
UAVS
$41.4M
$95K ﹤0.01%
+18
New +$98.7K
CPUH.WS
4391
DELISTED
Compute Health Acquisition Corp. Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50
CPUH.WS
$94K ﹤0.01%
+62,500
New +$76.3K
AVDL
4392
DELISTED
Avadel Pharmaceuticals
AVDL
$92K ﹤0.01%
+13,636
New +$108K
MSPRZ
4393
DELISTED
MSP Recovery Inc Warrant
MSPRZ
$92K ﹤0.01%
100,000
NUVB.WS
4394
DELISTED
Nuvation Bio Inc Warrants
NUVB.WS
$91K ﹤0.01%
34,975
-426
-1% -$1.39K
LGV.WS
4395
DELISTED
Longview Acquisition Corp. II Redeemable Warrants, each whole Warrant exercisable for one share of Class A Common Stock, each at an exercise price of $11.50 per share
LGV.WS
$91K ﹤0.01%
+66,666
New +$83.7K
FLXN
4396
DELISTED
Flexion Therapeutics, Inc.
FLXN
$91K ﹤0.01%
11,078
-52,563
-83% -$447K
ACIC icon
4397
American Coastal Insurance
ACIC
$498M
$90K ﹤0.01%
15,767
-7,400
-32% -$45.3K
CASA
4398
DELISTED
Casa Systems, Inc. Common Stock
CASA
$89K ﹤0.01%
10,030
-64,990
-87% -$576K
ESM.WS
4399
DELISTED
ESM Acquisition Corporation Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
ESM.WS
$89K ﹤0.01%
+88,419
New +$71.2K
FABC
4400
Fabric.AI Inc
FABC
$16.8M
$88K ﹤0.01%
141
+36
+34% +$23.7K

Similar funds

D.E. Shaw & Co's Q2 2021 Portfolio in Review

As of Q2 2021, D.E. Shaw & Co held 5,208 positions worth $116B, up 12% from $104B the previous quarter. Its ten largest holdings account for 9.9% of the portfolio.

D.E. Shaw & Co's Q2 2021 filing shows 1,193 new, 1,491 increased, 1,580 reduced and 489 closed positions. Its largest new stake was Weatherford International: 4,894,906 shares worth $89.1M. The largest sale was Microsoft, an estimated $672M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 16% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • D.E. Shaw & Co's largest Q2 2021 buy was Weatherford International: 4,894,906 shares worth $89.1M.
  • D.E. Shaw & Co added most to Just Eat Takeaway.com N.V. American Depositary Shares in Q2 2021, an estimated $700M increase.
  • D.E. Shaw & Co's biggest Q2 2021 reduction was Microsoft, cutting an estimated $672M.
  • D.E. Shaw & Co fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $131M.
  • D.E. Shaw & Co's ten largest holdings make up 9.9% of its $116B portfolio in Q2 2021.
  • D.E. Shaw & Co opened 1,193 new positions and closed 489 in Q2 2021.
  • D.E. Shaw & Co's portfolio value rose 12% quarter-over-quarter to $116B.

Based on D.E. Shaw & Co's 13F filing for Q2 2021, filed 16 Aug 2021.